Literature DB >> 1454842

DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice.

E P Sandgren1, R D Palmiter, J L Heckel, R L Brinster, J L Degen.   

Abstract

Hepatocyte-directed production of urokinase-type plasminogen activator (uPA) in transgenic mice is hepatotoxic. Infrequently, hepatocytes arise that do not express uPA, due to physical loss of transgene DNA, and these cells clonally repopulate the entire liver within 3 months of birth. Surprisingly, hepatic tumors appear in these mice beginning at 8 months of age despite the fact that uPA is not oncogenic or genotoxic. Analysis of the transgene locus reveals that tumors arise only from a particular subclass of transgene-deficient cells in which the entire transgene array, and possibly a significant amount of flanking DNA, is deleted. Considering that all transgene-deficient regenerative nodules undergo extensive replication but only a subset gives rise to tumors, we propose that loss of genomic DNA, not mitogenesis per se, is a primary carcinogenic determinant in this model of hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454842      PMCID: PMC50584          DOI: 10.1073/pnas.89.23.11523

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Genomic instability and cancer: cause and effect.

Authors:  K C Cheng; M O Diaz
Journal:  Cancer Cells       Date:  1991-05

Review 2.  Rate-limiting steps: the genetics of pediatric cancers.

Authors:  D A Haber; D E Housman
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

3.  Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator.

Authors:  J L Heckel; E P Sandgren; J L Degen; R D Palmiter; R L Brinster
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

4.  Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.

Authors:  H A Dunsford; S Sell; F V Chisari
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

5.  Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene.

Authors:  E P Sandgren; R D Palmiter; J L Heckel; C C Daugherty; R L Brinster; J L Degen
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

Review 6.  Does chemically induced hepatocyte proliferation predict liver carcinogenesis?

Authors:  R L Melnick
Journal:  FASEB J       Date:  1992-06       Impact factor: 5.191

Review 7.  Liver lesions in B6C3F1 mice: the National Toxicology Program, experience and position.

Authors:  R R Maronpot; J K Haseman; G A Boorman; S E Eustis; G N Rao; J E Huff
Journal:  Arch Toxicol Suppl       Date:  1987

8.  Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice.

Authors:  F V Chisari; P Filippi; J Buras; A McLachlan; H Popper; C A Pinkert; R D Palmiter; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 9.  Tumor suppressor genes.

Authors:  R A Weinberg
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

10.  Model for the incidence of embryonal cancers: application to retinoblastoma.

Authors:  H W Hethcote; A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

View more
  13 in total

Review 1.  Liver repopulation and carcinogenesis: two sides of the same coin?

Authors:  Fabio Marongiu; Silvia Doratiotto; Stefania Montisci; Paolo Pani; Ezio Laconi
Journal:  Am J Pathol       Date:  2008-03-05       Impact factor: 4.307

2.  Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes.

Authors:  T C Weglarz; J L Degen; E P Sandgren
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Stable long-term germ-line transmission of transgene integration sites in mice.

Authors:  B Aigner; M Fleischmann; M Müller; G Brem
Journal:  Transgenic Res       Date:  1999-02       Impact factor: 2.788

4.  Hepatocyte-specific deletion of DDB1 induces liver regeneration and tumorigenesis.

Authors:  Sachie Yamaji; Mingjun Zhang; Jing Zhang; Yoko Endo; Elena Bibikova; Stephen P Goff; Yong Cang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

Review 5.  Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.

Authors:  M A Feitelson; L X Duan
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.

Authors:  T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.

Authors:  Donna N Douglas; Toshiyasu Kawahara; Banu Sis; David Bond; Karl P Fischer; D Lorne J Tyrrell; Jamie T Lewis; Norman M Kneteman
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

8.  Transgenic hepatocarcinogenesis in the rat.

Authors:  J R Hully; Y Su; J K Lohse; A E Griep; C A Sattler; M J Haas; Y Dragan; J Peterson; M Neveu; H C Pitot
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

9.  Instability of long inverted repeats within mouse transgenes.

Authors:  A Collick; J Drew; J Penberth; P Bois; J Luckett; F Scaerou; A Jeffreys; W Reik
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

Review 10.  Experimental models of hepatocellular carcinoma.

Authors:  Philippa Newell; Augusto Villanueva; Scott L Friedman; Kazuhiko Koike; Josep M Llovet
Journal:  J Hepatol       Date:  2008-01-30       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.